Is COMT rs4680 AA linked to lower COMT activity and slower dopamine and norepinephrine metabolism?

The catechol-O-methyltransferase (COMT) gene plays a pivotal role in modulating central nervous system signaling, with its well-characterized rs4680 single nucleotide polymorphism serving as a primary genetic driver of variation in neurotransmitter clearance.

Biochemical and mechanistic insights

• Protein destabilization: The rs4680 AA (Met/Met) genotype dictates a functional valine-to-methionine substitution at codon 108/158, which compromises the structural and thermal stability of the COMT protein at physiological temperature (37 °C).
• Reduced enzymatic capacity: Because the Met-containing enzyme is thermolabile and denatures more readily, individuals with the AA genotype exhibit a 40% to 60% reduction in catalytic activity ($V_{max}$) and a three- to four-fold reduction in overall COMT enzymatic activity compared to those with the high-activity GG (Val/Val) genotype.

Impact on neurotransmitter kinetics

• Slower cortical clearance: In brain regions like the prefrontal cortex, where rapid transporter-mediated clearance is sparse, COMT serves as the primary degradation pathway for catecholamines.
• Elevated catecholamine tone: The three- to four-fold reduction in enzymatic activity in AA homozygotes directly retards the degradation of dopamine and norepinephrine, resulting in prolonged synaptic neurotransmitter action and higher baseline catecholamine levels compared to the rapid clearance state seen in GG homozygotes.

Bottom line

• The COMT rs4680 AA genotype encodes a thermolabile enzyme variant that reduces catalytic activity by 40% to 60%, directly resulting in a three- to four-fold reduction in overall activity and significantly slower clearance of dopamine and norepinephrine compared to the GG genotype.